Abdi R Khokhar

Title: Abdi R Khokhar: Innovator in Antitumor Platinum Complexes

Introduction

Abdi R Khokhar is a notable inventor based in Houston, Texas. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel antitumor agents. His work focuses on synthesizing platinum complexes that exhibit promising activity against resistant tumor models.

Latest Patents

Khokhar holds a patent for "Diamine platinum complexes as antitumor agents." This patent describes the synthesis of novel 1,4-diaminocyclohexane platinum II and platinum IV complexes. These complexes demonstrate in vivo activity against tumor models that are resistant to traditional treatments such as cis-platin and tetraplatin. The innovative complexes utilize various leaving ligands, including sulfato, chloro, hydroxyl, acetato, methylmalonato, tartronato, and 1,1-cyclobutane dicarboxylato, while employing 1,4-DACH amine as a non-leaving ligand. The complexes have shown significant in vitro cytotoxic activity against murine leukemia L1210/0 and human ovarian A2780 cell lines. Furthermore, they exhibit high in vivo activity against L1210 leukemia cells, including those resistant to cis-platin and tetraplatin. Notably, these platinum complexes do not indicate nephrotoxicity in in vivo tests.

Career Highlights

Abdi R Khokhar is affiliated with the University of Texas System, where he continues to advance his research in the field of cancer therapeutics. His work has garnered attention for its potential to improve treatment options for patients with resistant tumors.

Collaborations

Khokhar collaborates with Zahid H Siddik, contributing to the advancement of research in antitumor agents.

Conclusion

Abdi R Khokhar's innovative work in synthesizing platinum complexes represents a significant advancement in the fight against cancer. His contributions have the potential to lead to more effective treatments for patients facing resistant tumors.